VIGORITA, Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.160
EU - Europa 3.047
AS - Asia 1.447
SA - Sud America 487
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 2
Totale 8.201
Nazione #
US - Stati Uniti d'America 3.102
RU - Federazione Russa 1.501
SG - Singapore 609
CN - Cina 460
BR - Brasile 417
IE - Irlanda 401
SE - Svezia 391
UA - Ucraina 198
DE - Germania 163
HK - Hong Kong 143
IT - Italia 98
FI - Finlandia 77
FR - Francia 75
GB - Regno Unito 70
IN - India 55
VN - Vietnam 51
CA - Canada 25
AR - Argentina 23
PL - Polonia 16
UZ - Uzbekistan 15
MX - Messico 14
CO - Colombia 13
ZA - Sudafrica 13
BD - Bangladesh 12
IQ - Iraq 12
IR - Iran 12
ES - Italia 10
TR - Turchia 10
BE - Belgio 8
ID - Indonesia 8
MA - Marocco 8
EC - Ecuador 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
JO - Giordania 6
JP - Giappone 6
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
CR - Costa Rica 5
GR - Grecia 5
MY - Malesia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PT - Portogallo 4
RS - Serbia 4
SA - Arabia Saudita 4
BO - Bolivia 3
GT - Guatemala 3
JM - Giamaica 3
LB - Libano 3
NL - Olanda 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
NI - Nicaragua 2
PE - Perù 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
PS - Palestinian Territory 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 8.181
Città #
Moscow 443
Dublin 400
Ashburn 369
Jacksonville 353
Dallas 337
Singapore 328
Chandler 275
Nyköping 265
Dearborn 188
San Jose 184
Beijing 167
Hong Kong 143
Council Bluffs 119
The Dalles 79
Cambridge 62
Medford 61
Princeton 61
Los Angeles 60
Lauterbourg 52
Ann Arbor 45
Boardman 40
Des Moines 37
Buffalo 35
São Paulo 33
New York 31
Munich 28
Jinan 26
Ho Chi Minh City 25
Tianjin 23
Lancaster 21
San Mateo 21
Phoenix 19
Columbus 17
Guangzhou 14
Santa Clara 14
Warsaw 14
Chennai 13
Tashkent 13
Belo Horizonte 12
Haikou 12
Montreal 12
Rio de Janeiro 12
Turku 12
Woodbridge 12
Brasília 11
Frankfurt am Main 11
Wilmington 11
Ardabil 10
Hanoi 10
Shenyang 10
Atlanta 9
Houston 9
Milan 9
Nanchang 9
Orem 9
Brussels 8
Johannesburg 8
Nanjing 8
Seattle 8
Stockholm 8
Denver 7
San Francisco 7
Turin 7
Bremen 6
Brooklyn 6
Changsha 6
Charlotte 6
Chicago 6
Contagem 6
Curitiba 6
Guarulhos 6
Hebei 6
London 6
Redondo Beach 6
Amman 5
Asunción 5
Baghdad 5
Boston 5
Brno 5
Campinas 5
Dhaka 5
Fuzhou 5
Goiânia 5
Hangzhou 5
Monmouth Junction 5
Ningbo 5
Pune 5
Shanghai 5
Sorocaba 5
Taiyuan 5
Taizhou 5
Tokyo 5
Washington 5
Zhengzhou 5
Augusta 4
Bogotá 4
Helsinki 4
Indore 4
Istanbul 4
Louisville 4
Totale 4.846
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 260
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 212
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 198
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 194
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 187
FLUOROCONTAINING D-CYCLOSERINES - SYNTHESIS AND INVITRO EVALUATION OF ANTIMICROBIAL AND ANTIVIRAL ACTIVITIES 184
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 180
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 179
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 178
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 176
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 174
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 173
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 173
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 170
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 168
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 164
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 162
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 161
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 161
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 154
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 152
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 151
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 149
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 146
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 137
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 135
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 132
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 131
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 130
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 130
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 126
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 125
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 119
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 115
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 115
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 113
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 112
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 112
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 110
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 109
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 108
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 107
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 107
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 107
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 105
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 105
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 104
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 103
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 102
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 102
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 102
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 99
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 95
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 95
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 95
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 93
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 89
Metal(II) complexes with isoniazid analogues: synthesis and pharmacological activity 87
Reattività di isonicotinoilidrazoni con diazometano 81
Metalchelati di aroilidrazoni. Sintesi e valutazione dell'attività antitubercolare 79
Nuclear magnetic resonance spectra of psychotherapeutic agents. III. Stereochemistry of 1-methyl5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-diones 79
Totale 8.201
Categoria #
all - tutte 27.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022310 0 0 0 10 22 0 27 14 6 27 70 134
2022/20231.161 94 130 57 100 76 118 27 57 476 9 17 0
2023/2024204 16 34 32 13 24 42 1 13 0 3 0 26
2024/20251.093 13 9 19 79 42 33 42 212 297 65 107 175
2025/20263.550 180 318 296 241 241 788 438 417 403 128 64 36
2026/2027400 47 118 155 80 0 0 0 0 0 0 0 0
Totale 8.201